Fralin Biomedical Research Institute spinoff company translates science into peptide drugs targeting cancer stem cells
November 18, 2024
November 18, 2024
BLACKSBURG, Virginia, Nov. 18 -- Virginia Tech issued the following news:
Scientific progress often follows a prolonged path, but bioentrepreneur Samy Lamouille believes his dedication toward this pursuit will ultimately pay off for brain cancer patients.
Acomhal Research Inc. is a biotech startup that Lamouille and co-founder Rob Gourdie spun out of their research at the Fralin Biomedical Research Institute at VTC in 2016.
The company, dedicated to providi . . .
Scientific progress often follows a prolonged path, but bioentrepreneur Samy Lamouille believes his dedication toward this pursuit will ultimately pay off for brain cancer patients.
Acomhal Research Inc. is a biotech startup that Lamouille and co-founder Rob Gourdie spun out of their research at the Fralin Biomedical Research Institute at VTC in 2016.
The company, dedicated to providi . . .